Interestingly, besides lower white matter hyperintensity volumes and higher neocortical tau PET in amnestic EOAD compared to amnestic LOAD, no differences in other AD- and co-pathologies, such as MTL tau-PET, and our proxy of TDP-43 were observed between amnestic EOAD and LOAD. The gene discussed is MAPT; the disease is Alzheimer disease.